<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-14-42663</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0110304</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories>
<title-group>
<article-title>Correction: Targeting GRB7/ERK/FOXM1 Signaling Pathway Impairs Aggressiveness of Ovarian Cancer Cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><collab xlink:type="simple">The <italic>PLOS ONE</italic> Staff</collab></contrib>
</contrib-group>
<pub-date pub-type="collection"><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>6</day><month>10</month><year>2014</year></pub-date>
<volume>9</volume>
<issue>10</issue>
<elocation-id>e110304</elocation-id><permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>The PLOS ONE Staff</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article id="RA1" related-article-type="corrected-article" ext-link-type="uri" page="e52578" xlink:type="simple" xlink:href="info:doi/10.1371/journal.pone.0052578"><article-title>Targeting GRB7/ERK/FOXM1 Signaling Pathway Impairs Aggressiveness of Ovarian Cancer Cells</article-title></related-article><counts><page-count count="2"/></counts></article-meta>
</front>
<body><sec id="s1">
<title/>
<p>There is an error in in Figure 3. Incorrect pictures were erroneously used in Figure 3A. Please see the corrected Figure 3 here.</p>
<fig id="pone-0110304-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0110304.g001</object-id><label>Figure 3</label><caption>
<title>Inhibition of ERK phosphorylation or FOXM1 significantly decreased both migration and invasion of GRB7-overexpressing ovarian cancer cells.</title>
<p>OVCA433 cells with stable expression of GFP/GRB7 (OVCA433-GRB7) were treated with DMSO as control, Thiostrepton (20 µM), PD98059 (20 µM) and U0126 (10 µM) for 6 hours and were analyzed by (A) Transwell cell migration assay. The representative pictures and bar chart showed significant reduction in the number of migratory cells through Matrigel-coated membrane in OVCA433-GRB7 cells treated with Thiostrepton, PD98059 and U0126 than DMSO control (*P&lt;0.02, Student t-test) at 8-hour; (B) Transwell cell invasion assay. The representative pictures and bar chart showed significant reduction in the invasion rate in OVCA433-GRB7 cells treated with Thiostrepton, PD98059 and U0126 when compared with DMSO control (*P&lt;0.05, Student t-test) at 15-hour.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0110304.g001" position="float" xlink:type="simple"/></fig></sec></body>
<back><ref-list>
<title>Reference</title>
<ref id="pone.0110304-Chan1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chan</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Hui</surname><given-names>WWY</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>PCH</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>MX</given-names></name>, <name name-style="western"><surname>Yung</surname><given-names>MMH</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Targeting GRB7/ERK/FOXM1 Signaling Pathway Impairs Aggressiveness of Ovarian Cancer Cells</article-title>. <source>PLoS ONE</source> <volume>7(12)</volume>: <fpage>e52578</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0052578" xlink:type="simple">10.1371/journal.pone.0052578</ext-link></comment></mixed-citation>
</ref>
</ref-list></back>
</article>